Skip to content
April 24, 2014 / Cathy Kim

Takeda to Pay $6 Billion in Actos Cancer Lawsuits

On April 7, 2014, a federal court in Louisiana ordered Japanese drug maker Takeda Pharmaceutical Co. Ltd. to pay $6 billion in punitive damages in settlement of allegations that the company concealed information regarding the risk for cancer associated with its diabetes drug Actos.  Eli Lilly and Co., a co-defendant in the case, was ordered to pay $3 billion in punitive damages and $1.45 billion in compensatory damages.  This was the first federal case to be tried in a consolidated multidistrict litigation comprising of more than 2,900 lawsuits. 

Actos is a member of class of drugs known as thiazolidinediones, used to treat type 2 diabetes.  The side effects of Actos include increased risk for bladder cancer, congestive heart failure, serious liver problems, and fractures.  According to Eli Lilly and Co., 75 percent of the liability was allocated to Takeda and 25 percent to Lilly.  Takeda plans to appeal the award, stating that judgments were entered in its favor in all three previous Actos trials. 

If you or someone you know has been affected by the drug Actos, please contact Khorrami Boucher, LLP for a consultation.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

Consumer Advocate Legal Update

Insight and Commentary on Consumer Legal Issues


Insight and Commentary on Individual Rights

Fair Employment Legal Update

Insight and Commentary on Legal Employment Issues

KB News

Legal Updates and News About Khorrami Boucher, LLP

%d bloggers like this: